| Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19 M Tomazou, MM Bourdakou, G Minadakis, M Zachariou, A Oulas, ... Briefings in bioinformatics 22 (6), bbab114, 2021 | 33 | 2021 |
| Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains A Oulas, M Zanti, M Tomazou, M Zachariou, G Minadakis, MM Bourdakou, ... PloS one 16 (1), e0238665, 2021 | 33 | 2021 |
| Rapid and sensitive assessment of globin chains for gene and cell therapy of hemoglobinopathies CC Loucari, P Patsali, TB van Dijk, C Stephanou, P Papasavva, M Zanti, ... Human Gene Therapy Methods 29 (1), 60-74, 2018 | 26 | 2018 |
| Performance evaluation of pipelines for mapping, variant calling and interval padding, for the analysis of NGS germline panels M Zanti, K Michailidou, MA Loizidou, C Machattou, P Pirpa, ... BMC bioinformatics 22 (1), 218, 2021 | 12 | 2021 |
| NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases M Zanti, MA Loizidou, K Michailidou, P Pirpa, C Machattou, Y Marcou, ... Cancers 12 (11), 3140, 2020 | 11 | 2020 |
| Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction K Yiangou, N Mavaddat, J Dennis, M Zanti, Q Wang, MK Bolla, ... medRxiv, 2024 | 9 | 2024 |
| In depth analysis of Cyprus-specific mutations of SARS-CoV-2 strains using computational approaches A Oulas, J Richter, M Zanti, M Tomazou, K Michailidou, K Christodoulou, ... BMC Genomic Data 22, 1-15, 2021 | 4 | 2021 |
| Alport syndrome: Proteomic analysis identifies early molecular pathway alterations in Col4a3 knock out mice O Nicolaou, A Kousios, K Sokratous, L Potamiti, L Koniali, G Neophytou, ... Nephrology 25 (12), 937-949, 2020 | 4 | 2020 |
| Saturation genome editing-based clinical classification of BRCA2 variants S Sahu, M Galloux, E Southon, D Caylor, T Sullivan, M Arnaudi, M Zanti, ... Nature, 1-8, 2025 | 2 | 2025 |
| A Likelihood Ratio Approach for Utilizing Case‐Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2 M Zanti, DG O′ Mahony, MT Parsons, H Li, J Dennis, K Aittomäkkiki, ... Human mutation 2023 (1), 9961341, 2023 | 2 | 2023 |
| In silico assessment of the structural, functional and stability impact of a nonsense PRF1 mutation with uncertain clinical significance; identified in 2 unrelated Cypriot … M Zanti, MA Loizidou, M Zachariou, K Michailidou, K Kyriacou, ... 2019 IEEE 19th International Conference on Bioinformatics and Bioengineering …, 2019 | 2 | 2019 |
| Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls M Zanti, MA Loizidou, DG O’Mahony, L Dorling, J Dennis, P Devilee, ... Frontiers in Genetics 14, 1248492, 2023 | 1 | 2023 |
| Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction K Yiangou, N Mavaddat, J Dennis, M Zanti, Q Wang, MK Bolla, ... Breast Cancer Research 26 (1), 189, 2024 | | 2024 |
| Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification M Zanti, DG O’Mahony, MT Parsons, L Dorling, J Dennis, NJ Boddicker, ... medRxiv, 2024 | | 2024 |
| Large scale case-control analyses of rare variant data; application to BRCA1 and BRCA2 D O'Mahony, M Zanti, MT Parsons, J Dennis, C Fortuno, M Vreeswijk, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 53-53, 2024 | | 2024 |
| Dennis M Zanti, M Loizidou, DG O'Mahon, L Dorling De ilee, P.,… Michailidou, K, 2023 | | 2023 |
| Dennis,., ittomäkkiki M Zanti, DG O'Mahon, MT Parsons, H Li K.,… Michailidou, K, 2023 | | 2023 |
| Case-control likelihood ratio calculation for clinical classification of variants of uncertain significance in the BRCA1 and BRCA2 genes M Zanti, F Couch, D O'Mahony, J Dennis, D Easton, A Spurdle, D Goldgar, ... EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 376-377, 2022 | | 2022 |
| A comprehensive in silico analysis of the functional, structural and stability impact of the PALB2 p. Leu1143His variant of uncertain clinical significance. M Zanti, MA Loizidou, K Michailidou, C Machattou, P Pirpa, GM Spyrou, ... EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 672-672, 2020 | | 2020 |
| NGS panel testing of negative BRCA1/2 index patients with Triple-Negative Breast Cancer in Cyprus M Zanti, MA Loizidou, K Michailidou, P Pirpa, C Machattou, Y Markou, ... EUROPEAN JOURNAL OF HUMAN GENETICS 27, 1602-1603, 2019 | | 2019 |
